TABLE 1.
Variable | All participants (n = 20) | Women (n = 10) | Men (n = 10) | P |
Age, y | 63 ± 8 | 63 ± 9 | 64 ± 6 | 0.33 |
Systolic blood pressure, mm Hg | 118 ± 15 | 114 ± 9 | 123 ± 6 | 0.23 |
Diastolic blood pressure, mm Hg | 70 ± 8 | 66 ± 7 | 74 ± 6 | 0.0182 |
BMI, kg/m2 | 27.1 ± 3.0 | 26.4 ± 3.3 | 27.7 ± 6 | 0.45 |
Waist circumference, cm | 90.6 ± 10.2 | 84.4 ± 7.9 | 97.0 ± 6 | 0.0030 |
Hip circumference, cm | 102.4 ± 5.8 | 103.4 ± 6.6 | 101.0 ± 6 | 0.46 |
Waist-to-hip ratio | 0.9 ± 0.1 | 0.8 ± 0.0 | 1.0 ± 6 | 0.0004 |
Body composition in whole body, % | ||||
Total fat | 29.9 ± 7.8 | 35.7 ± 5.4 | 24.0 ± 6 | <0.0001 |
Lean mass | 67.4 ± 7.9 | 61.5 ± 5.0 | 73.3 ± 6 | <0.0001 |
Lean mass plus bone mineral content | 70.3 ± 8.2 | 64.3 ± 5.4 | 76.3 ± 6 | 0.0001 |
Body composition in abdominal region, % | ||||
Total fat | 29.0 ± 6.6 | 29.4 ± 7.0 | 28.5 ± 6 | 0.47 |
Lean mass | 70.4 ± 6.5 | 70.0 ± 6.8 | 71.0 ± 6 | 0.45 |
Lean mass plus bone mineral content | 71.0 ± 6.6 | 70.6 ± 7.0 | 71.5 ± 6 | 0.74 |
Body composition in trunk region, % | ||||
Total fat | 29.8 ± 7.9 | 36.0 ± 5.5 | 24.3 ± 6 | <0.0001 |
Lean mass | 67.2 ± 8.3 | 61.0 ± 5.4 | 73.4 ± 6 | 0.0009 |
Lean mass plus bone mineral content | 69.6 ± 8.6 | 63.3 ± 5.7 | 76.0 ± 6 | 0.0001 |
hs-CRP,2 mg/L | 2.4 ± 2.2 | 2.6 ± 2.0 | 2.2 ± 6 | 0.55 |
Glucose,2 mmol/L | 5.1 ± 0.4 | 4.9 ± 0.4 | 5.3 ± 6 | 0.0189 |
Insulin,2 mU/L | 14.1 ± 7.6 | 13.5 ± 8.2 | 14.7 ± 6 | 0.72 |
HbA1c,2 % | 5.5 ± 0.3 | 5.3 ± 0.1 | 5.6 ± 6 | 0.07 |
NEFA,2 mmol/L | 0.4 ± 0.1 | 0.4 ± 0.1 | 0.3 ± 6 | 0.0301 |
Serum lipids,2 mmol/L | ||||
Total cholesterol | 4.4 ± 0.7 | 4.7 ± 0.6 | 4.2 ± 6 | 0.12 |
Triacylglycerol | 1.5 ± 0.5 | 1.5 ± 0.6 | 1.5 ± 6 | 0.89 |
HDL cholesterol | 1.1 ± 0.3 | 1.3 ± 0.3 | 1.0 ± 6 | 0.0130 |
LDL cholesterol | 2.6 ± 0.6 | 2.7 ± 0.6 | 2.5 ± 6 | 0.55 |
Physical activity, 1000 kcal/wk | 4.0 ± 2.2 | 4.3 ± 2.1 | 3.6 ± 6 | 0.44 |
All values are means ± SDs. A comparison of baseline characteristics between female and male participants was done with the use of an unpaired t test. HbA1c, glycated hemoglobin; hs-CRP, high-sensitivity C-reactive protein; NEFA, nonesterified fatty acid.
Measured at baseline (4 h postbreakfast) and immediately before the white-bread or glucose-drink challenge.